1. Home
  2. DNN vs NMRA Comparison

DNN vs NMRA Comparison

Compare DNN & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

N/A

Current Price

$3.03

Market Cap

2.9B

ML Signal

N/A

Logo Neumora Therapeutics Inc.

NMRA

Neumora Therapeutics Inc.

N/A

Current Price

$1.04

Market Cap

302.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DNN
NMRA
Founded
1954
2019
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
302.0M
IPO Year
1998
2023

Fundamental Metrics

Financial Performance
Metric
DNN
NMRA
Price
$3.03
$1.04
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$6.50
$7.50
AVG Volume (30 Days)
26.1M
687.0K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.23
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$403.36
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$0.83
52 Week High
$4.43
$3.65

Technical Indicators

Market Signals
Indicator
DNN
NMRA
Relative Strength Index (RSI) 46.94 28.21
Support Level $3.13 $0.83
Resistance Level $3.41 $1.74
Average True Range (ATR) 0.17 0.09
MACD -0.03 -0.03
Stochastic Oscillator 5.34 0.96

Price Performance

Historical Comparison
DNN
NMRA

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is engaged in uranium mining-related activities, including the acquisition, exploration, development, and mining of uranium-bearing properties, as well as the processing, sale, and investment in uranium. The company's key properties include Wheeler River, Waterbury Lake, McClean Lake, Midwest, and others. It operates through two segments: the Mining segment and the Corporate and Other segment. The majority of the company's revenue is generated from the Mining segment, which includes activities related to exploration, evaluation, and development, mining, milling (including toll milling), and the sale of mineral concentrates.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: